Sickle Cell Ribbon Color: What It Means & Why It Matters

·

Share

The sickle cell ribbon color is red — and it’s one of the most recognizable awareness ribbons in hematology. The red ribbon represents the fight against sickle cell disease (SCD), a genetic blood disorder that affects approximately 100,000 Americans and millions more worldwide. Red was chosen deliberately: it symbolizes the blood cells at the heart of the disease, the urgency of the cause, and the strength of the community living with SCD.

If you’ve seen someone wearing a red ribbon in September — Sickle Cell Awareness Month — or at a community health event, they’re standing in solidarity with the roughly 20 million people globally affected by this condition. But the ribbon is more than a fashion statement. It’s a call to action for better research funding, earlier diagnosis, and equitable access to treatments that can genuinely save lives.

Why Red? The Story Behind the Sickle Cell Ribbon Color

Awareness ribbons carry meaning through color. Pink for breast cancer, purple for Alzheimer’s, gold for childhood cancer. The red ribbon for sickle cell disease draws a direct visual connection to red blood cells — the very cells that become distorted into a rigid, crescent (sickle) shape in people with SCD.

The Sickle Cell Disease Association of America (SCDAA) and advocacy groups worldwide have adopted the red ribbon as the universal emblem of the cause. You’ll see it on pins, T-shirts, social media profile frames, and event banners, particularly during September awareness campaigns.

Ribbon Color Condition Awareness Month
Red Sickle Cell Disease September
Orange Leukemia September
Burgundy Multiple Myeloma March
Purple Hodgkin Lymphoma September
Green Lymphoma (Non-Hodgkin) September
Red (also) Blood Cancer (general) September

Yes, red is shared with a few other causes — including heart disease and HIV/AIDS. Context matters. When you see a red ribbon paired with a crescent-shaped cell graphic or the words “sickle cell,” there’s no ambiguity.

What Exactly Is Sickle Cell Disease?

Sickle cell disease is caused by a mutation in the HBB gene, which provides instructions for making beta-globin, a component of hemoglobin. The mutation produces an abnormal form called hemoglobin S (HbS). When HbS loses oxygen, it polymerizes — essentially stacking into rigid rods that warp the red blood cell into a sickle shape.

These sickled cells are sticky, inflexible, and short-lived. Normal red blood cells survive about 120 days; sickled cells die in 10–20 days. This creates chronic hemolytic anemia and triggers a cascade of complications.

Key Facts at a Glance

  • Inheritance: Autosomal recessive — a child must inherit one HbS gene from each parent
  • Prevalence: ~100,000 affected in the U.S.; 1 in every 365 Black or African American births
  • Sickle cell trait: ~1 in 13 Black or African American babies carry one copy (carriers are generally asymptomatic)
  • Global burden: ~300,000 babies born with SCD annually, predominantly in sub-Saharan Africa, India, and the Middle East
  • Life expectancy: Median survival has improved to 45–55 years in high-income countries, up from under 20 years in the 1970s

Why the Ribbon Matters: Disparities in Funding and Care

Here’s a stark reality that fuels the urgency behind the red ribbon. Sickle cell disease affects roughly the same number of Americans as cystic fibrosis (~33,000 vs. ~100,000). Yet historically, cystic fibrosis has received 3–10 times more research funding per patient from the NIH and private foundations.

SCD disproportionately affects Black and Hispanic communities, and the funding gap reflects broader health equity failures. The red ribbon is a deliberate push against this disparity — a visible reminder that this disease deserves the same research investment, specialist access, and public attention as any other genetic condition.

How to Show Your Support

Wearing the ribbon is a start, but meaningful support goes further:

  • Donate blood. Patients with SCD may need regular transfusions. Matched blood from donors of African descent is particularly needed.
  • Support legislation. The Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act has expanded federal programs — advocacy helped make it happen.
  • Get tested. If you or your partner carry sickle cell trait, genetic counseling before starting a family can provide critical information.
  • Educate yourself. Stigma and misunderstanding (especially around pain management in emergency rooms) remain serious barriers to care.
  • Participate in September awareness events. Walks, blood drives, educational seminars, and social media campaigns all amplify visibility.

Breakthrough Treatments Giving the Ribbon New Meaning

For decades, hydroxyurea was the only FDA-approved drug for SCD. It works by boosting fetal hemoglobin (HbF), which inhibits the sickling process and can reduce pain crises by 44%. It remains a cornerstone of therapy.

But the landscape has shifted dramatically since 2019:

  • Voxelotor (Oxbryta): Approved 2019, directly inhibits HbS polymerization. Note: voluntarily withdrawn from market in September 2024 after post-marketing safety review.
  • Crizanlizumab (Adakveo): Anti-P-selectin antibody that reduces vaso-occlusive crises. Also withdrawn in 2024 after confirmatory trials didn’t meet endpoints.
  • L-glutamine (Endari): Approved 2017, reduces oxidative stress in sickled cells.
  • Casgevy (exagamglogene autotemcel): FDA-approved December 2023 — the first CRISPR-based gene therapy for any disease. Uses gene editing to reactivate fetal hemoglobin production. Early data shows 97% of patients were free of vaso-occlusive crises for at least 12 months post-treatment.
  • Lyfgenia (lovotibeglogene autotemcel): Also approved December 2023, a gene therapy using a lentiviral vector to introduce anti-sickling hemoglobin.

These gene therapies represent something the red ribbon community has waited generations for: the realistic possibility of a functional cure. They’re expensive (over $2 million per treatment) and logistically complex, but they’re here.

When to See a Doctor

If you or your child has sickle cell disease or sickle cell trait, stay connected with a hematologist. Seek urgent care for:

  • Fever above 101.3°F (38.5°C) — infections can escalate quickly in SCD
  • Severe pain crisis not controlled by home medications
  • Sudden vision changes (possible retinal vessel occlusion)
  • Signs of stroke: facial drooping, arm weakness, speech difficulty
  • Acute chest syndrome symptoms: chest pain, cough, fever, shortness of breath
  • Priapism lasting more than 2 hours

Frequently Asked Questions

What color ribbon is for sickle cell disease?

The sickle cell awareness ribbon is red. It symbolizes the red blood cells affected by the disease and is worn prominently during Sickle Cell Awareness Month in September.

Is the sickle cell ribbon the same as the AIDS ribbon?

Both causes use red ribbons, which can cause confusion. The sickle cell ribbon is typically accompanied by a crescent or sickle-shaped cell graphic to distinguish it. Context — the event, the organization, the messaging — usually makes the distinction clear.

Can you have sickle cell disease if you’re not Black?

Yes. While SCD disproportionately affects people of African descent, it also occurs in people of Mediterranean, Middle Eastern, Indian, and Hispanic backgrounds. The sickle cell gene evolved in regions where malaria was prevalent because carrying one copy (sickle cell trait) provides partial malaria resistance.

Is sickle cell disease curable now?

As of 2024, bone marrow transplant (from a matched sibling donor) and the newly approved gene therapies Casgevy and Lyfgenia offer the closest thing to a cure. Gene therapy in particular has shown remarkable early results, though long-term follow-up data is still being collected and access remains limited by cost and infrastructure.

Where can I get a sickle cell awareness ribbon?

Red awareness ribbon pins and merchandise are available through the Sickle Cell Disease Association of America (sicklecelldisease.org), local SCD foundations, and online retailers. Many organizations distribute them free during September awareness events.

Written by
Haematology, Platelet Biology
Contact [email protected] AmandaUnsworth1 Website Manchester Metropolitan University June 26, 2020 Repurposing anti-cancer drugs: Could Pim kinase inhibitors be the new aspirin? My scientific interests are in understanding the signalling molecules and pathways that regulate platelet function, thrombosis and haemostasis. My research aims to understand the role platelets play in pathological conditions which is essential for the identification of drug targets,…
View Full Profile →
Web Admin Avatar